Alessandro Rizzi il 11/05/2025

Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study

Diabetes Res Clin Pract. 2025 May 9:112244. doi: 10.1016/j.diabres.2025.112244. Online ahead of print.ABSTRACTAIMS: A very-low-dose regimen of the anti-factor Xa rivaroxaban combined with low-dose aspirin reduces vascular events more than aspirin alone in atherosclerotic patients, including those wi

Yiting He il 09/05/2025

Association between hemoglobin, albumin, lymphocyte, and platelet score and all-cause and cardiovascular mortality among population with diabetes: Evidence from the NHANES 2003-2016

Diabetes Res Clin Pract. 2025 May 7;224:112212. doi: 10.1016/j.diabres.2025.112212. Online ahead of print.ABSTRACTINTRODUCTION: This study investigated the relationship between the Hemoglobin, Albumin, Lymphocyte, and Platelets (HALP) score and all-cause and cardiovascular mortality risk in diabetes

Nancy Samir Elbarbary il 08/05/2025

Periodontal disease in adolescents with type 1 diabetes mellitus: A cross link between continuous glucose monitoring-derived metrics, caspase-3 levels, diabetic nephropathy and subclinical atherosclerosis

Diabetes Res Clin Pract. 2025 May 8;224:112234. doi: 10.1016/j.diabres.2025.112234. Online ahead of print.ABSTRACTBACKGROUND: Periodontitis can lead to the development of atherosclerotic heart disease.AIM: To assess the relation between periodontal disease and continuous glucose monitoring (CGM)-der

Urby Saraf Anika il 07/05/2025

Diabetes care cascade in Bangladesh: Identifying gaps and social determinants

Diabetes Res Clin Pract. 2025 May 5;224:112227. doi: 10.1016/j.diabres.2025.112227. Online ahead of print.ABSTRACTAIMS: Precise and up-to-date data regarding the care gaps is essential to prioritize interventions and guide efficient resource allocation for management of diabetes in Bangladesh. The a

Antonio García-Hermoso il 06/05/2025

Development and validation of a scale measuring perceived barriers to physical activity in Spanish for children and adolescents with type 1 diabetes: the Physical Activity Barriers Scale for pediatric type 1 diabetes (PABS-1) questionnaire

Diabetes Res Clin Pract. 2025 May 4;224:112223. doi: 10.1016/j.diabres.2025.112223. Online ahead of print.ABSTRACTAIMS: To develop and validate the psychometric properties, reliability, and criterion validity of the Physical Activity Barriers Scale for pediatric type 1 diabetes (PABS-1) in Spanish-s

Yuanyuan Gao il 05/05/2025

Regulation of pancreatic β cells by exosomes from different sources

Diabetes Res Clin Pract. 2025 May 3;224:112222. doi: 10.1016/j.diabres.2025.112222. Online ahead of print.ABSTRACTDiabetes is a chronic metabolic disorder with rising global prevalence, particularly in developed and high-income regions. Central to its pathogenesis is the dysfunction of pancreatic β-

Angela Y Su il 05/05/2025

Comparative efficacy and safety of SGLT2 inhibitor class members in patients with heart failure and type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials

Diabetes Res Clin Pract. 2025 May 3;224:112219. doi: 10.1016/j.diabres.2025.112219. Online ahead of print.ABSTRACTWe conducted a systematic review with pairwise (PMA) and network meta-analyses (NMA) to evaluate sodium-glucose transport protein 2 inhibitor (SGLT2i) effects in patients with both heart

Carolina Ferraz Figueiredo Moreira il 04/05/2025

Effect of vitamin D supplementation on glycemic control in children and adolescents with type 1 diabetes mellitus: Data from a controlled clinical trial

Diabetes Res Clin Pract. 2025 May 2;224:112210. doi: 10.1016/j.diabres.2025.112210. Online ahead of print.ABSTRACTAIM: To evaluate the effect of vitamin D supplementation on vitamin D deficiency (VDD) and glycemic control in children and adolescents with type 1 diabetes mellitus (T1DM).METHODS: This